Advertisement
News
Advertisement

WaferGen Appoints World-Renowned Clinical Genomics Cancer Researcher Dr. Arul M. Chinnaiyan to Scientific Advisory Board

Wed, 01/19/2011 - 4:32am
Bio-Medicine.Org

FREMONT, Calif., Jan. 19, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced that it has appointed world-renowned clinical genomics cancer researcher Arul M. Chinnaiyan, M.D., Ph.D., to its Scientific Advisory Board.  

Dr. Chinnaiyan is a recognized leader in the use of biomarkers in the clinic to choose appropriate therapies for cancer patients.  Biomarkers are characteristics that are measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.  Dr. Chinnaiyan has led the characterization of a number of biomarkers of prostate cancer including AMACR, EZH2, hepsin, and sarcosine. His laboratory identified recurrent ETS gene fusions in prostate cancer, potentially redefining the molecular basis of prostate cancer as well as other common epithelial cancers.  His laboratory also developed Oncomine (www.oncomine.org), a popular cancer profiling bioinformatics resource.

Biomarker expertise is important to WaferGen as the WaferGen SmartChip system, with its 5000+ nano-well format, is designed to provide faster, more cost-effective biomarker identification and validation for multiple samples and patients.

"WaferGen understands what is needed for high-throughput biomarker profiling in order to complement targeted therapies.  I am eager to share my clinical knowledge to help build even better genomic analysis products," said Dr. Chinnaiyan.

"Dr. Chinnaiyan's insight into the use of biomarkers in the clinic will be invaluable to support WaferGen's development of impactful products for genomics analysis including current product selection as well as future molecular diagnostics programs," said Alnoor Shivji, Waf

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading